Case studies
Outcomes, not overstatements.
Real teams, real numbers. Here's what changed when oncology centers, rare-disease programs and pharma R&D groups pointed the beam at their hardest data.
Oncology · Meridian Oncology
Read the case study
Rare Disease · Helix Nordic
Read the case study
Pharma R&D · Polaris Genomics
Read the case study
Tumor-board prep from 9 days to 11 hours.
A comprehensive cancer center unified somatic, germline and RNA evidence into one signed report — and doubled weekly throughput.
11 hPrep time
2.4×Cases / week
100%Audit coverage
+38% diagnostic yield on unsolved trios.
By fusing genome, transcriptome and methylation, a national program re-solved cases that had been open for years.
38%Yield uplift
640+Families solved
7 hTrio turnaround
A trial-ready biomarker in one quarter.
A biotech discovery team mined a multi-omic cohort to define and validate a response signature — 6× faster than their legacy stack.
6×Faster discovery
0.91Validation AUC
Q1To readiness
Population Genomics
Your program could be next.
Running a biobank or population initiative? Let's talk about cohort-scale analysis with zero data movement.
Talk to us1.2MSamples analyzed
14Genomics centers
38%Avg. yield uplift
6×Faster cohorts
Write the next one with us.
See BeamMedic on your own data — book a walkthrough with a genomics specialist.